6815.TWO Diamond Biotechnology Co., Ltd

Healthcare Medical Devices Taiwan OTC Exchange
19.00 TWD
Close of Nov 6, 2026
18.50 72.00
Market cap
TWD 750M
P/E
-
P/B
1.36x
ROE
-13.0%
Dividend yield
0.88%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6815.TWO undervalued?

Graham number

The Graham number of Diamond Biotechnology Co., Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Diamond Biotechnology Co., Ltd fundamental analysis

No fundamental analysis for Diamond Biotechnology Co., Ltd yet.

Diamond Biotechnology Co., Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Diamond Biotechnology Co., Ltd

Diamond Biotechnology Co., Ltd engages in the research, development, manufacture, and sale of health care products and medical consumables in Taiwan and internationally. The company offers Miracle Thread, an absorbable synthetic surgical suture device made of polydioxanone; UTIMS, a high-intensity focused ultrasound; Letybo, a frozen crystal injection; TEOSYAL RHA invisible resilient hyaluronic acid; Ronkyla, a sodium deoxycholate injection; S+DIAMOND skincare products. It a…

Full company profile